Amgen 2012 Annual Report Download - page 88

Download and view the complete annual report

Please find page 88 of the 2012 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 150

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150

81
PART IV
Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(a)1. Index to Financial Statements
The following Consolidated Financial Statements are included herein:
Page
number
Report of Independent Registered Public Accounting Firm
Consolidated Statements of Income for each of the three years in the period ended December 31, 2012
Consolidated Statements of Comprehensive Income for each of the three years in the period ended
December 31, 2012
Consolidated Balance Sheets at December 31, 2012 and 2011
Consolidated Statements of Stockholders’ Equity for each of the three years in the period ended
December 31, 2012
Consolidated Statements of Cash Flows for each of the three years in the period ended
December 31, 2012
Notes to Consolidated Financial Statements
(a)2. Index to Financial Statement Schedules
The following Schedule is filed as part of this Annual Report on Form 10-K:
Page
number
II. Valuation and Qualifying Accounts
All other schedules are omitted because they are not applicable, not required or because the required information is included
in the consolidated financial statements or notes thereto.
(a)3. Exhibits
Exhibit No. Description
3.1 Restated Certificate of Incorporation of Amgen Inc. (As Restated December 7, 2005). (Filed as an exhibit
to Form 10-K for the year ended December 31, 2005 on March 10, 2006 and incorporated herein by
reference.)
3.2 Certificate of Amendment to the Restated Certificate of Incorporation of Amgen Inc. (As Amended May
24, 2007). (Filed as an exhibit to Form 10-Q for the quarter ended June 30, 2007 on August 9, 2007 and
incorporated herein by reference.)
3.3 Certificate of Correction of Restated Certificate of Incorporation of Amgen Inc. (As Corrected May 24,
2007). (Filed as an exhibit to Form 10-Q for the quarter ended June 30, 2007 on August 9, 2007 and
incorporated herein by reference.)
3.4 Certificate of Elimination of the Certificate of Designations of the Series A Junior Participating Preferred
Stock (As Eliminated December 9, 2008). (Filed as an exhibit to Form 10-K for the year ended December
31, 2008 on February 27, 2009 and incorporated herein by reference.)
3.5* Certificate of Change of Location of Registered Office and of Registered Agent of Amgen Inc. (As Changed
January 2, 2009).
F-1
F-2
F-3
F-4
F-5
F-6
F-7
F-51